5篇
您的检索式：作者名="Daniel Reshef"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Synthesis of WS_(2)and MoS_(2)Fullerene-Like Nanoparticles from Solid Precursors显示文摘Inorganic fullerene-like WS_(2)and MoS_(2)nanoparticles have been synthesized using exclusively solid precursors,by reaction of the corresponding metal oxide nanopowder,sulfur and a hydrogen-releasing agent(NaBH4 or LiAlH4),achieved either by conventional furnace heating up to~900℃or by photothermal ablation at far higher temperatures driven by highly concentrated white light.In contrast to the established syntheses that require toxic and hazardous gases,working solely with solid precursors permits relatively safer reactor conditions conducive to industrial scale-up. | Inna Wiesel Hamutal Arbel Ana Albu-Yaron Ronit Popovitz-Biro Jeffrey MGordon Daniel Feuermann Reshef Tenne | 2009 | Nano Research2009，2，5： | 2 |
| 2 | In Situ TEM Measurements of the Mechanical Properties and Behavior of WS_(2)Nanotubes显示文摘The mechanical properties of individual WS2 nanotubes were investigated and directly related to their atomic structure details by in situ transmission electron microscope measurements.A brittle mode deformation was observed in bending tests of short(ca.1μm in length)multilayer nanotubes.This mode can be related to the atomic structure of their shells.In addition,longer nanotubes(67μm in length)were deformed in situ scanning electron microscope,but no plastic deformation was detected.A“sword-in-sheath”fracture mechanism was revealed in tensile loading of a nanotube,and the sliding of inner shells inside the outermost shell was imaged“on-line”.Furthermore,bending modulus of 217 GPa was obtained from measurements of the electric-fi eld-induced resonance of these nanotubes. | Ming Sheng Wang Ifat Kaplan-Ashiri Xian Long Wei Rita Rosentsveig Hanoch Daniel Wagner Reshef Tenne Lian Mao Peng | 2008 | Nano Research2008，1，1： | 1 |
| 3 | 在药品研发及商业化全程实施药品安全科学管理规范(三)显示文摘为系统阐述和研究药品安全科学,全面引入药品风险管理理念,国家药品不良反应监测中心特邀请国外相关专家共同撰写了《在药品研发及商业化全程实施药品安全科学管理规范》一文,并将其译成中文以共享。 | Kasia Petchel Rebecca Wang Gary Slatko Daniel Reshef Michael Peng 陈易新 | 2009 | 中国药物警戒2009，6，3： | 1 |
| 4 | 在药品研发及商业化全程实施药品安全科学管理规范(一)显示文摘为系统阐述和研究药品安全科学,全面引入药品风险管理理念,国家药品不良反应监测中心特邀请国外相关专家共同撰写了《在药品研发及商业化全程实施药品安全科学管理规范》一文,并将其译成中文以共享。 | Kasia Petchel Rebecca Wang Gary Slatko Daniel Reshef Michael Peng 陈易新 | 2009 | 中国药物警戒2009，6，1： | 0 |
| 5 | 在药品研发及商业化全程实施药品安全科学管理规范(二)显示文摘为系统阐述和研究药品安全科学,全面引入药品风险管理理念,国家药品不良反应监测中心特邀请国外相关专家共同撰写了《在药品研发及商业化全程实施药品安全科学管理规范》一文,并将其译成中文以共享。 | Kasia Petchel Rebecca Wang Gary Slatko Daniel Reshef Michael Peng 陈易新 | 2009 | 中国药物警戒2009，6，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员